Is normoglycemia a reachable state in safe, effective glycemic control in critical care? A review and steady-state analysis showing the need for dual insulin and nutrition control - 2026
Is normoglycemia a reachable state in safe, effective glycemic control in critical care? A review and steady-state analysis showing the need for dual insulin and nutrition control
Chase, J. Geoffrey; Seret, Marie; Uyttendaele, Vincentet al.
2026 • In Annual Reviews in Control, 62, p. 101072
Control; Critical care; Decision support; EGP; Endogenous glucose production; Glycemic control; ICU; Insulin; Insulin saturation; Insulin sensitivity; Intensive care unit; Nutrition; Physiological model; Decision supports; Endogenous glucose; Glucose production; Intensive care; Control and Systems Engineering; Software
Abstract :
[en] Critically ill patients frequently experience stress-induced hyperglycemia, leading to increased morbidity and mortality. Safe, effective glycemic control (GC) with insulin therapy alone has proven difficult to achieve consistently. One successful, personalized and model-based GC system overcomes this issue by modulating nutrition, as well as insulin, to control glucose levels. However, no other published protocol takes this approach. Thus, the question arises on whether both control inputs are required to be able to reach normoglycemia safely and effectively. This work uses a well-validated metabolic system model to show how nonlinear insulin saturation dynamics, and the interaction of insulin sensitivity with nutrition and insulin inputs, combine to require modulation of nutrition as well as insulin to achieve a desired outcome glycemic level – effectively analysing the ability of glycemic control to reach normoglycemia. In doing so, it also shows without nutrition control, insulin resistant patients will be uncontrollable to a given glycemic level in a theoretical sense and derives the mathematical conditions when this situation occurs. Next, it derives how insulin sensitivity variability, common in intensive care unit (ICU) patients as condition evolves, leads to changes in glucose levels, increasing hyper- and hypo- glycemic risk if nutrition is not controlled to allow lower insulin doses and thus a reduced range of glycemic variability. The analysis is augmented by a shared visual analysis, illustrating the metabolic dynamics to provide better insight and understanding. The primary result is a mathematical, clinical, and control centred review and analysis of the clinical glycemic control problem in the context of assessing the conditions for normoglycemia to be reached safely and consistently. It mathematically demonstrates the necessity of using nutrition modulation, along with controlling insulin, to achieve safe, effective GC for all patients when nonlinear clinical and physiological limits are considered. This main outcome is contrary to a lot of current clinical practice and thinking, and contrary to a strictly mathematical analysis without consideration of known, but often ignored, nonlinear physiological and clinical limitations.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others
Author, co-author :
Chase, J. Geoffrey ; University of Canterbury, Department of Mechanical Engineering, Centre for Bioengineering, Christchurch, New Zealand
Seret, Marie ; Université de Liège - ULiège > Département des sciences cliniques
Uyttendaele, Vincent ; Université de Liège - ULiège > Département d'astrophysique, géophysique et océanographie (AGO) > Thermodynamique des phénomènes irréversibles
Knopp, Jennifer L.; University of Canterbury, Department of Mechanical Engineering, Centre for Bioengineering, Christchurch, New Zealand
Shannon, Helen; OCTO, Chester, United Kingdom
Desaive, Thomas ; Université de Liège - ULiège > Département d'astrophysique, géophysique et océanographie (AGO) > Thermodynamique des phénomènes irréversibles
Language :
English
Title :
Is normoglycemia a reachable state in safe, effective glycemic control in critical care? A review and steady-state analysis showing the need for dual insulin and nutrition control
Ali, N.A., O'Brien, J.M. Jr., Dungan, K., Phillips, G., Marsh, C.B., Lemeshow, S., Connors, A.F. Jr., Preiser, J.C., Glucose variability and mortality in patients with sepsis. Critical Care Medicine 36:8 (2008), 2316–2321.
Amrein, K., Ellmerer, M., Hovorka, R., Kachel, N., Parcz, D., Korsatko, S., Smolle, K., Perl, S., Bock, G., Doll, W., Kohler, G., Pieber, T.R., Plank, J., Hospital glucose control: Safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. Diabetes Technology & Therapeutics 12:5 (2010), 405–412.
Bagshaw, S.M., Bellomo, R., Jacka, M.J., Egi, M., Hart, G.K., George, C., The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Critical Care (London, England), 13(3), 2009, R91.
Beardsall, K., Vanhaesebrouck, S., Ogilvy-Stuart, A.L., Vanhole, C., VanWeissenbruch, M., Midgley, P., Thio, M., Cornette, L., Ossuetta, I., Palmer, C.R., Iglesias, I., de Jong, M., Gill, B., de Zegher, F., Dunger, D.B., Validation of the continuous glucose monitoring sensor in preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition 98:2 (2013), F136–F140.
Beardsall, K., Thomson, L., Elleri, D., Dunger, D.B., Hovorka, R., Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition, 2019.
Black, P.R., Brooks, D.C., Bessey, P.Q., Wolfe, R.R., Wilmore, D.W., Mechanisms of insulin resistance following injury. Annals of Surgery 196:4 (1982), 420–435.
Blaha, J., Hovorka, R., Matias, M., Kotulak, T., Kremen, J., Sloukova, A., Svacina, S., Haluzik, M., Intensive insulin therapy in critically ill patients: Comparison of standard and MPC protocols. Intensive Care Medicine, 31(S1), 2005, S203.
Blaha, J., Kopecky, P., Matias, M., Hovorka, R., Kunstyr, J., Kotulak, T., Lips, M., Rubes, D., Stritesky, M., Lindner, J., Semrad, M., Haluzik, M., Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care 32:5 (2009), 757–761.
Blaha, J., Barteczko-Grajek, B., Berezowicz, P., Charvat, J., Chvojka, J., Grau, T., Holmgren, J., Jaschinski, U., Kopecky, P., Manak, J., Moehl, M., Paddle, J., Pasculli, M., Petersson, J., Petros, S., Radrizzani, D., Singh, V., Starkopf, J., Space GlucoseControl system for blood glucose control in intensive care patients–a European multicentre observational study. BMC Anesthesiology, 16, 2015, 8.
Cahill, N.E., Dhaliwal, R., Day, A.G., Jiang, X., Heyland, D.K., Nutrition therapy in the critical care setting: What is "best achievable" practice? An international multicenter observational study. Critical Care Medicine 38:2 (2010), 395–401.
Cai, S., Hu, Y., Hong, Y., Qian, L., Lin, S., Lin, X., Zhong, M., Zhang, Y., Development and validation of a machine learning model for real-time blood glucose prediction for ICU patients. BMC Medical Informatics and Decision Making, 26(1), 2025, 14.
Casaer, M.P., Wilmer, A., Hermans, G., Wouters, P.J., Mesotten, D., Van den Berghe, G., Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: A post hoc analysis. American Journal of Respiratory and Critical Care Medicine 187:3 (2013), 247–255.
Cerra, F.B., Benitez, M.R., Blackburn, G.L., Irwin, R.S., Jeejeebhoy, K., Katz, D.P., Pingleton, S.K., Pomposelli, J., Rombeau, J.L., Shronts, E., Wolfe, R.R., Zaloga, G.P., Applied nutrition in ICU patients. A consensus statement of the American college of chest physicians. Chest 111:3 (1997), 769–778.
Chambrier, C., Laville, M., Berrada K, R., Odeon, M., Bouletreau, P., Beylot, M., Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clinical Science (Lond) 99:4 (2000), 321–328.
Chase, J.G., Dickson, J.L., Traversing the valley of glycemic control despair. Critical care (London, England), 21(1), 2017, 237.
Chase, J.G., Shaw, G.M., Lin, J., Doran, C.V., Bloomfield, M., Wake, G., Broughton, B., Hann, C., Lotz, T., Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia. International Journal of Intelligent Systems Technologies and Applications, 1(1), 2005, 79.
Chase, J., Shaw, G., Wong, X., Lotz, T., Lin, J., Hann, C., Model-based glycaemic control in critical care—A review of the state of the possible. Biomedical Signal Processing and Control 1:1 (2006), 3–21.
Chase, J.G., Shaw, G., Le Compte, A., Lonergan, T., Willacy, M., Wong, X.W., Lin, J., Lotz, T., Lee, D., Hann, C., Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: A clinical practice change. Critical Care (London, England), 12(2), 2008, R49.
Chase, J.G., Pretty, C.G., Pfeifer, L., Shaw, G.M., Preiser, J.C., Le Compte, A.J., Lin, J., Hewett, D., Moorhead, K.T., Desaive, T., Organ failure and tight glycemic control in the SPRINT study. Critical Care (London, England), 14(4), 2010, R154.
Chase, J.G., Suhaimi, F., Penning, S., Preiser, J.C., Le Compte, A.J., Lin, J., Pretty, C.G., Shaw, G.M., Moorhead, K.T., Desaive, T., Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomedical Engineering Online, 9, 2010, 84.
Chase, J.G., Le Compte, A.J., Preiser, J.C., Shaw, G.M., Penning, S., Desaive, T., Physiological modeling, tight glycemic control, and the ICU clinician: What are models and how can they affect practice?. Annals of Intensive Care, 1(1), 2011, 11.
Chase, J.G., Le Compte, A.J., Suhaimi, F., Shaw, G.M., Lynn, A., Lin, J., Pretty, C.G., Razak, N., Parente, J.D., Hann, C.E., Tight glycemic control in critical care-the leading role of insulin sensitivity and patient variability: A review and model-based analysis. Computer Methods and Programs in Biomedicine 102:2 (2011), 156–171.
Chase, J., Desaive, T., Preiser, J.C., Virtual patients and virtual cohorts: A new way to think about the design and implementation of personalized icu treatments. Vincent, J.L., (eds.) Annual update in intensive care and emergency medicine, 2016, 435–448.
Chase, J.G., Desaive, T., Bohe, J., Cnop, M., De Block, C., Gunst, J., Hovorka, R., Kalfon, P., Krinsley, J., Renard, E., Preiser, J.C., Improving glycemic control in critically ill patients: Personalized care to mimic the endocrine pancreas. Critical Care (London, England), 22(1), 2018, 182.
Chase, J.G., Preiser, J.C., Dickson, J.L., Pironet, A., Chiew, Y.S., Pretty, C.G., Shaw, G.M., Benyo, B., Moeller, K., Safaei, S., Tawhai, M., Hunter, P., Desaive, T., Next-generation, personalised, model-based critical care medicine: A state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them. Biomedical Engineering Online, 17(1), 2018, 24.
Chase, J.G., Benyo, B., Desaive, T., Glycemic control in the intensive care unit: A control systems perspective. Annual Reviews in Control 48 (2019), 359–368.
Chase, J., Zhou, C., Knopp, J.L., Moeller, K., Benyo, B., Desaive, T., Wong, J.H., Malinen, S., Naswall, K., Shaw, G.M., Digital twins and automation of care in the intensive care unit. Cyber–Physical–Human systems: Fundamentals and applications, 2023, Wiley-IEEE Press, 457–489.
Chowdhury, S.A., Shin, G.Y., Lee, S.E., Han, S.-S., Kim, S.R., Lee, Y.-K., Park, J., Multicenter retrospective study of offline reinforcement learning for insulin dosing during parenteral to enteral nutrition transition in ICU patients. Scientific Reports, 2026.
Davidson, S., Pretty, C., Uyttendaele, V., Knopp, J., Desaive, T., Chase, J.G., Multi-input stochastic prediction of insulin sensitivity for tight glycaemic control using insulin sensitivity and blood glucose data. Computer Methods and Programs in Biomedicine, 182, 2019, 105043.
Dickson, J.L., Hewett, J.N., Gunn, C.A., Lynn, A., Shaw, G.M., Chase, J.G., On the problem of patient-specific endogenous glucose production in neonates on stochastic targeted glycemic control. Journal of Diabetes Science and Technology 7:4 (2013), 913–927.
Dickson, J., Gunn, C., Chase, J., Humans are horribly variable. International Journal of Clinical and Medical Imaging, 1(2), 2014, 1 page, 1000142.
Dickson, J.L., Stewart, K.W., Pretty, C.G., Flechet, M., Desaive, T., Penning, S., Lambermont, B.C., Benyo, B., Shaw, G.M., Chase, J.G., Generalisability of a virtual trials method for glycaemic control in Intensive care. IEEE Transactions on Bio-Medical Engineering 65:7 (2018), 1543–1553.
Docherty, P.D., Chase, J.G., Lotz, T., Hann, C.E., Shaw, G.M., Berkeley, J.E., Mann, J., McAuley, K., DISTq: An iterative analysis of glucose data for low-cost, real-time and accurate estimation of insulin sensitivity. The Open Medical Informatics Journal 3 (2009), 65–76.
Docherty, P.D., Chase, J.G., Hann, C.E., Lotz, T.F., Lin, J., McAuley, K.A., Shaw, G.M., The identification of insulin saturation effects during the dynamic insulin sensitivity test. The Open Medical Informatics Journal 4 (2010), 141–148.
Docherty, P.D., Chase, J.G., Lotz, T.F., Desaive, T., A graphical method for practical and informative identifiability analyses of physiological models: A case study of insulin kinetics and sensitivity. Biomedical Engineering Online, 10(1), 2011, 39.
Docherty, P.D., Chase, J.G., Lotz, T.F., Hann, C.E., Shaw, G.M., Berkeley, J.E., TeMorenga, L., Mann, J.I., McAuley, K., Independent cohort cross-validation of the real-time DISTq estimation of insulin sensitivity. Computer Methods and Programs in Biomedicine 102:2 (2011), 94–104.
Docherty, P.D., Chase, J.G., Morenga, L., Lotz, T.F., Berkeley, J., Shaw, G., McAuley, K., Mann, J., A spectrum of dynamic insulin sensitivity test protocols. Journal of Diabetes Science and Technology 5:6 (2011), 1499–1508.
Docherty, P.D., Chase, J.G., David, T., Characterisation of the iterative integral parameter identification method. Medical and Biological Engineering and Computing, 2012, 1–8.
Doyle, F.J.III, Kovatchev, B.P., Artificial pancreas: The first 20 years. 2025, SAGE Publications Sage CA, Los Angeles, CA, 875–882.
Dubois, J., Van Herpe, T., van Hooijdonk, R.T., Wouters, R., Coart, D., Wouters, P., Van Assche, A., Veraghtert, G., De Moor, B., Wauters, J., Wilmer, A., Schultz, M.J., Van den Berghe, G., Mesotten, D., Software-guided versus nurse-directed blood glucose control in critically ill patients: The LOGIC-2 multicenter randomized controlled clinical trial. Critical Care (London, England), 21(1), 2017, 212.
Dupuis, C., Preiser, J.C., Busch, R.A., Coursin, D.B., Long, M.T., Nutrition interventions and post–Intensive care syndrome: A narrative review. Nutrition in Clinical Practice 41:2 (2026), 375–392.
Eaton, R.P., Allen, R.C., Schade, D.S., Hepatic removal of insulin in normal man: Dose response to endogenous insulin secretion. The Journal of Clinical Endocrinology & Metabolism 56:6 (1983), 1294–1300.
Eaton, R.P., Friedman, N., Allen, R.C., Schade, D.S., Insulin removal in man: In vivo evidence for a receptor-mediated process. The Journal of Clinical Endocrinology & Metabolism 58:3 (1984), 555–559.
Egi, M., Bellomo, R., Reducing glycemic variability in intensive care unit patients: A new therapeutic target?. Journal of Diabetes Science and Technology 3:6 (2009), 1302–1308.
Egi, M., Bellomo, R., Stachowski, E., French, C.J., Hart, G., Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:2 (2006), 244–252.
Egi, M., Bellomo, R., Stachowski, E., French, C.J., Hart, G.K., Taori, G., Hegarty, C., Bailey, M., Hypoglycemia and outcome in critically ill patients. Mayo Clinic Proceedings 85:3 (2010), 217–224.
Evans, A., Shaw, G.M., Le Compte, A., Tan, C.S., Ward, L., Steel, J., Pretty, C.G., Pfeifer, L., Penning, S., Suhaimi, F., Pilot proof of concept clinical trials of stochastic targeted (STAR) glycemic control. Annals of Intensive Care, 1(1), 2011, 38.
Evans, A., Le Compte, A., Tan, C.S., Ward, L., Steel, J., Pretty, C.G., Penning, S., Suhaimi, F., Shaw, G.M., Desaive, T., Stochastic targeted (STAR) glycemic control: Design, safety, and performance. Journal of Diabetes Science and Technology 6:1 (2012), 102–115.
Faulds, E.R., Rayan, M.N., Mlachak, M., Dungan, K.M., Allen, T., Patterson, E., Artificial intelligence algorithms for insulin management and hypoglycemia prevention in hospitalized patients—A scoping review. Diabetology, 7(1), 2026, 19.
Fernandez-Real, J.M., Broch, M., Richart, C., Vendrell, J., Lopez-Bermejo, A., Ricart, W., CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. The Journal of Clinical Endocrinology and Metabolism 88:4 (2003), 1780–1784.
Ferrannini, E., Cobelli, C., The kinetics of insulin in man. II. Role of the liver. Diabetes/Metabolism Reviews 3:2 (1987), 365–397.
Ferrannini, E., Cobelli, C., The kinetics of insulin in man. I. General aspects. Diabetes/Metabolism Reviews 3:2 (1987), 335–363.
Ferrannini, E., Wahren, J., Faber, O.K., Felig, P., Binder, C., DeFronzo, R.A., Splanchnic and renal metabolism of insulin in human subjects: A dose-response study. American Journal of Physiology 244:6 (1983), E517–E527.
Finfer, S., Liu, B., Chittock, D.R., Norton, R., Myburgh, J.A., McArthur, C., Mitchell, I., Foster, D., Dhingra, V., Henderson, W.R., Ronco, J.J., Bellomo, R., Cook, D., McDonald, E., Dodek, P., Hebert, P.C., Heyland, D.K., Robinson, B.G., Hypoglycemia and risk of death in critically ill patients. The New England Journal of Medicine 367:12 (2012), 1108–1118.
Finfer, S., Wernerman, J., Preiser, J.C., Cass, T., Desaive, T., Hovorka, R., Joseph, J.I., Kosiborod, M., Krinsley, J., Mackenzie, I., Mesotten, D., Schultz, M.J., Scott, M.G., Slingerland, R., Van den Berghe, G., Van Herpe, T., Clinical review: Consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Critical Care (London, England), 17(3), 2013, 229.
Fisk, L., Lecompte, A., Penning, S., Desaive, T., Shaw, G., Chase, G., STAR development and protocol comparison. IEEE Transactions on Bio-Medical Engineering 59:12 (2012), 3357–3364.
Furushima, N., Egi, M., Obata, N., Sato, H., Satoshi, M., Mean amplitude of glycemic excursions in septic patients and its association with outcomes: A prospective observational study using continuous glucose monitoring. Journal of Critical Care, 2020.
Galderisi, A., Facchinetti, A., Steil, G.M., Ortiz-Rubio, P., Cavallin, F., Tamborlane, W.V., Baraldi, E., Cobelli, C., Trevisanuto, D., Continuous glucose monitoring in very preterm infants: A randomized controlled trial. Pediatrics(4), 2017, 140.
Griesdale, D.E., de Souza, R.J., van Dam, R.M., Heyland, D.K., Cook, D.J., Malhotra, A., Dhaliwal, R., Henderson, W.R., Chittock, D.R., Finfer, S., Talmor, D., Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ : Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne 180:8 (2009), 821–827.
Gunst, J., Van den Berghe, G., Blood glucose control in the ICU: Don't throw out the baby with the bathwater!. Intensive Care Medicine 42:9 (2016), 1478–1481.
Gunst, J., Egi, M., Van den Berghe, G., Nutrition and metabolic control for ICU patients. Intensive Care Medicine, 2025, 1–3.
Heyland, D.K., Cahill, N., Day, A.G., Optimal amount of calories for critically ill patients: Depends on how you slice the cake!. Critical Care Medicine 39:12 (2011), 2619–2626.
Heyland, D.K., Critical care nutrition support research: Lessons learned from recent trials. Current Opinion in Clinical Nutrition and Metabolic Care 16:2 (2013), 176–181.
Holzinger, U., Warszawska, J., Kitzberger, R., Wewalka, M., Miehsler, W., Herkner, H., Madl, C., Real-time continuous glucose monitoring in critically ill patients: A prospective randomized trial. Diabetes Care 33:3 (2010), 467–472.
Hovorka, R., Continuous glucose monitoring and closed-loop systems. Diabetic Medicine 23:1 (2006), 1–12.
Iglesias Platas, I., Thio Lluch, M., Pociello Alminana, N., Morillo Palomo, A., Iriondo Sanz, M., Krauel Vidal, X., Continuous glucose monitoring in infants of very low birth weight. Neonatology 95:3 (2009), 217–223.
Ingels, C., Vanhorebeek, I., Van den Berghe, G., Glucose homeostasis, nutrition and infections during critical illness. Clinical Microbiology and Infection 24:1 (2018), 10–15.
Jacobs, B., Phan, K., Bertheau, L., Dogbey, G., Schwartz, F., Shubrook, J., Continuous glucose monitoring system in a rural intensive care unit: A pilot study evaluating accuracy and acceptance. Journal of Diabetes Science and Technology 4:3 (2010), 636–644.
Kalfon, P., Preiser, J.C., Tight glucose control: Should we move from intensive insulin therapy alone to modulation of insulin and nutritional inputs?. Critical Care (London, England), 12(3), 2008, 156.
Klonoff, D.C., Ahn, D., Drincic, A., Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Research and Clinical Practice 133 (2017), 178–192.
Klonoff, D.C., Wang, J., Rodbard, D., Kohn, M.A., Li, C., Liepmann, D., Kerr, D., Ahn, D., Peters, A.L., Umpierrez, G.E., A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. Journal of Diabetes Science and Technology, 2022, 19322968221085273.
Klonoff, D.C., Freckmann, G., Pleus, S., Kovatchev, B.P., Kerr, D., Tse, C., Li, C., Agus, M.S., Dungan, K., Voglová Hagerf, B., The diabetes technology society error grid and trend accuracy matrix for glucose monitors. Journal of Diabetes Science and Technology 18:6 (2024), 1346–1361.
Knopp, J.L., Lynn, A.M., Shaw, G.M., Chase, J.G., Safe and effective glycaemic control in premature infants: Observational clinical results from the computerised STAR-GRYPHON protocol. Archives of Disease in Childhood: Fetal and Neonatal Edition 104:2 (2019), F205–F211.
Knopp, J.L., Chase, J.G., Shaw, G.M., The goldilocks problem: Nutrition and its impact on glycaemic control. Clinical Nutrition 40:6 (2021), 3677–3687.
Kolterman, O.G., Insel, J., Saekow, M., Olefsky, J.M., Mechanisms of insulin resistance in human obesity: Evidence for receptor and postreceptor defects. Journal of Clinical Investigation 65:6 (1980), 1272–1284.
Kopecky, P., Mraz, M., Blaha, J., Lindner, J., Svacina, S., Hovorka, R., Haluzik, M., The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. BioMed Research International, 2013, 186439 2013.
Koschorreck, M., Gilles, E.D., Mathematical modeling and analysis of insulin clearance in vivo. BMC Systems Biology, 2, 2008, 43.
Kovatchev, B.P., Colmegna, P., Pavan, J., Diaz Castañeda, J.L., Villa-Tamayo, M.F., Koravi, C.L., Santini, G., Alix, C., Stumpf, M., Brown, S.A., Human-machine co-adaptation to automated insulin delivery: A randomised clinical trial using digital twin technology. Npj Digital Medicine, 8(1), 2025, 253.
Krinsley, J.S., Preiser, J.C., Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Critical care (London, England), 19, 2015, 179.
Krinsley, J.S., Chase, J.G., Gunst, J., Martensson, J., Schultz, M.J., Taccone, F.S., Wernerman, J., Bohe, J., De Block, C., Desaive, T., Kalfon, P., Preiser, J.C., Continuous glucose monitoring in the ICU: Clinical considerations and consensus. Critical care (London, England), 21(1), 2017, 197.
Krinsley, J.S., Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings 79:8 (2004), 992–1000.
Krishnan, J.A., Parce, P.B., Martinez, A., Diette, G.B., Brower, R.G., Caloric intake in medical ICU patients: Consistency of care with guidelines and relationship to clinical outcomes. Chest 124:1 (2003), 297–305.
Laakso, M., Edelman, S., Brechtel, G., Baron, A., Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. The Journal of Clinical Investigation 85:6 (1990), 1844–1852.
Langouche, L., Vander Perre, S., Wouters, P.J., D'Hoore, A., Hansen, T.K., Van den Berghe, G., Effect of intensive insulin therapy on insulin sensitivity in the critically ill. The Journal of Clinical Endocrinology & Metabolism 92:10 (2007), 3890–3897.
Lanspa, M.J., Krinsley, J.S., Hersh, A.M., Wilson, E.L., Holmen, J.R., Orme, J.F., Morris, A.H., Hirshberg, E.L., Percentage of time in range 70 to 139 mg/dL is associated with reduced mortality among critically ill patients receiving IV insulin infusion. Chest 156 (2019), 878–886.
Le Compte, A.J., Lynn, A.M., Lin, J., Pretty, C.G., Shaw, G.M., Chase, J.G., Pilot study of a model-based approach to blood glucose control in very-low-birthweight neonates. BMC Pediatrics, 12, 2012, 117.
LeCompte, A., Chase, J., Lynn, A., Hann, C., Shaw, G., Wong, X., Lin, J., Blood glucose controller for neonatal intensive care: Virtual trials development and 1st clinical trials. Journal of Diabetes Science and Technology (JoDST) 3:5 (2009), 1066–1081.
Lee, J.M., Newman, M.W., Gebremariam, A., Choi, P., Lewis, D., Nordgren, W., Costik, J., Wedding, J., West, B., Benovich Gilby, N., Hannemann, C., Pasek, J., Garrity, A., Hirschfeld, E., Real-world use and self-reported health outcomes of a patient-designed do-it-yourself mobile technology system for diabetes: Lessons for mobile health. Diabetes Technology & Therapeutics 19 (2017), 209–219.
Lewis, D., Leibrand, S., Open, A.P.S.C., Real-world use of open source artificial pancreas systems. Journal of Diabetes Science and Technology, 10(6), 2016, 1411.
Lin, J., Lee, D., Chase, J.G., Shaw, G.M., Hann, C.E., Lotz, T., Wong, J., Stochastic modelling of insulin sensitivity variability in critical care. Biomedical Signal Processing and Control 1:3 (2006), 229–242.
Lin, J., Lee, D., Chase, J.G., Shaw, G.M., Le Compte, A., Lotz, T., Wong, J., Lonergan, T., Hann, C.E., Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Computer Methods and Programs in Biomedicine 89:2 (2008), 141–152.
Lin, J., Razak, N.N., Pretty, C.G., Le Compte, A., Docherty, P., Parente, J.D., Shaw, G.M., Hann, C.E., Geoffrey Chase, J., A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Computer Methods and Programs in Biomedicine 102:2 (2011), 192–205.
Lonergan, T., LeCompte, A., Willacy, M., Chase, J.G., Shaw, G.M., Wong, X.W., Lotz, T., Lin, J., Hann, C.E., A simple insulin-nutrition protocol for tight glycemic control in critical illness: Development and protocol comparison. Diabetes Technology & Therapeutics 8:2 (2006), 191–206.
Lush, C.W., Kvietys, P.R., Microvascular dysfunction in sepsis. Microcirculation (New York, N.Y. : 1994) 7:2 (2000), 83–101.
Mari, A., Tura, A., Pacini, G., Kautzky-Willer, A., Ferrannini, E., Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabetic Medicine 25:6 (2008), 671–677.
Marik, P.E., Tight glycemic control in acutely ill patients: Low evidence of benefit, high evidence of harm!. Intensive Care Medicine 42:9 (2016), 1475–1477.
Martin, C.M., Doig, G.S., Heyland, D.K., Morrison, T., Sibbald, W.J., Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). CMAJ : Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne 170:2 (2004), 197–204.
McAuley, K.A., Berkeley, J.E., Docherty, P.D., Lotz, T.F., Te Morenga, L.A., Shaw, G.M., Williams, S.M., Chase, J.G., Mann, J.I., The dynamic insulin sensitivity and secretion test--A novel measure of insulin sensitivity. Metabolism 60 (2011), 1748–1756.
McCowen, K.C., Malhotra, A., Bistrian, B.R., Stress-induced hyperglycemia. Critical Care Clinics 17:1 (2001), 107–124.
McKinlay, C.J., Chase, J.G., Dickson, J., Harris, D.L., Alsweiler, J.M., Harding, J.E., Continuous glucose monitoring in neonates: A review. Maternal Health, Neonatology and Perinatology 3 (2017), 1–9.
Moghissi, E.S., Korytkowski, M.T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I.B., Inzucchi, S.E., Ismail-Beigi, F., Kirkman, M.S., Umpierrez, G.E., American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:6 (2009), 1119–1131.
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., Colette, C., Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295(14), 2006, 1681.
Natali, A., Gastaldelli, A., Camastra, S., Sironi, A.M., Toschi, E., Masoni, A., Ferrannini, E., Mari, A., Dose-response characteristics of insulin action on glucose metabolism: A non-steady-state approach. American Journal of Physiology Endocrinology and Metabolism 278:5 (2000), E794–E801.
Olefsky, J.M., Ciaraldi, T.P., Kolterman, O.G., Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. The American Journal of Medicine 79:3B (1985), 12–22.
Ormsbee, J.J., Knopp, J.L., Chase, J.G., Estimating increased EGP during stress response in critically ill patients. Journal of Diabetes Science and Technology 15:4 (2021), 856–864.
Othman, N.A., Docherty, P.D., Chase, J.G., Determining the relative efficacy of a number of PID and PD models that relate insulin secretion to bolus induced glucose excursions. IFAC Proceedings Volumes 47:3 (2014), 2100–2105.
Othman, N.A., Docherty, P.D., Damanhuri, N.S., Chase, J.G., Tracking the progression to type 2 diabetes with a proportional-derivative insulin secretion model. Control Engineering Practice 59 (2017), 165–172.
Payne, M., Pooke, F., Fulton, H., Shaw, H., Coulson, T., Knopp, J., Holder-Pearson, L., Campbell, J., Chase, J.G., Design of an open source ultra low cost insulin pump. HardwareX, 12, 2022, e00375.
Payne, M., Pooke, F., Wilkinson, T.M., Holder-Pearson, L., Chamberlain, B., de Bock, M., Chase, J.G., Single-arm, first-in-human feasibility study results for an ultra-low-cost insulin pump. BMC Endocrine Disorders, 24(1), 2024, 134.
Penning, S., Chase, J.G., Preiser, J.C., Pretty, C.G., Signal, M., Melot, C., Desaive, T., Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial. Journal of Critical Care 29:3 (2014), 374–379.
Penning, S., Pretty, C., Preiser, J.C., Shaw, G.M., Desaive, T., Chase, J.G., Glucose control positively influences patient outcome: A retrospective study. Journal of Critical Care 30:3 (2015), 455–459.
Plank, J., Blaha, J., Cordingley, J., Wilinska, M.E., Chassin, L.J., Morgan, C., Squire, S., Haluzik, M., Kremen, J., Svacina, S., Toller, W., Plasnik, A., Ellmerer, M., Hovorka, R., Pieber, T.R., Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. Diabetes Care 29:2 (2006), 271–276.
Preiser, J.C., Straaten, H.M., Glycemic control: Please agree to disagree. Intensive care medicine 42:9 (2016), 1482–1484.
Preiser, J.C., Wernerman, J., Provision of nutrients to the acutely ill. Introducing the "baby stomach" concept. American Journal of Respiratory and Critical Care Medicine 196:9 (2017), 1089–1090.
Preiser, J.C., van Zanten, A.R., Berger, M.M., Biolo, G., Casaer, M.P., Doig, G.S., Griffiths, R.D., Heyland, D.K., Hiesmayr, M., Iapichino, G., Laviano, A., Pichard, C., Singer, P., Van den Berghe, G., Wernerman, J., Wischmeyer, P., Vincent, J.L., Metabolic and nutritional support of critically ill patients: Consensus and controversies. Critical Care (London, England), 19, 2015, 35.
Preiser, J.C., Chase, J.G., Hovorka, R., Joseph, J.I., Krinsley, J.S., De Block, C., Desaive, T., Foubert, L., Kalfon, P., Pielmeier, U., Van Herpe, T., Wernerman, J., Glucose Control in the ICU: A continuing story. Journal of Diabetes Science and Technology 10:6 (2016), 1372–1381.
Preiser, J.-C., Fraipont, V., Lheureux, O., Le concept du «baby stomach» appliqué à la nutrition du patient agressé. Nutrition Clinique et Métabolisme 33 (2019), 167–172.
Pretty, C.G., Le Compte, A.J., Chase, J.G., Shaw, G.M., Preiser, J.C., Penning, S., Desaive, T., Variability of insulin sensitivity during the first 4 days of critical illness: Implications for tight glycemic control. Annals of Intensive Care, 2(1), 2012, 17.
Prigeon, R.L., Roder, M.E., Porte, D. Jr., Kahn, S.E., The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. Journal of Clinical Investigation 97:2 (1996), 501–507.
Reignier, J., Gaillard-Le Roux, B., Dequin, P.F., Bertoni Maluf, V.A., Bohe, J., Casaer, M.P., Delbove, A., Dupuis, C., Fontaine, E., Gamon, P., Expert consensus‑based clinical practice guidelines for nutritional support in the intensive care unit: The French Intensive Care Society (SRLF) and the French-Speaking Group of Pediatric Emergency Physicians and Intensivists (GFRUP). Annals of Intensive Care, 15(1), 2025, 99.
Rizza, R.A., Mandarino, L.J., Gerich, J.E., Dose-response characteristics for effects of insulin on production and utilization of glucose in man. American Journal of Physiology 240:6 (1981), E630–E639.
Seret, M., Uyttendaele, V., Chase, J.G., Desaive, T., In-silico assessment of longer measurement intervals in glycaemic control to match clinical practice. Computer Methods and Programs in Biomedicine, 267, 2025, 108806.
Seret, M., Uyttendaele, V., Chase, J.G., Shaw, G.M., Desaive, T., Tight glycemic control can be achieved in adult ICU patients safely: Results from a 5-year single-center observational study using the STAR glycemic control framework. Journal of Diabetes Science and Technology, 2026, 19322968251412857.
Signal, M., Pretty, C.G., Chase, J.G., Le Compte, A., Shaw, G.M., Continuous glucose monitors and the burden of tight glycemic control in critical care: Can they cure the time cost?. Journal of Diabetes Science and Technology 4:3 (2010), 625–635.
Signal, M., Le Compte, A., Shaw, G.M., Chase, J.G., Glycemic levels in critically ill patients: Are normoglycemia and low variability associated with improved outcomes?. Journal of Diabetes Science and Technology 6:5 (2012), 1030–1037.
Signal, M., Le Compte, A., Harris, D.L., Weston, P.J., Harding, J.E., Chase, J.G., Chyld Study, G., Impact of retrospective calibration algorithms on hypoglycemia detection in newborn infants using continuous glucose monitoring. Diabetes Technology & Therapeutics 14:10 (2012), 883–890.
Signal, M., Fisk, L., Shaw, G.M., Chase, J.G., Concurrent continuous glucose monitoring in critically ill patients: Interim results and observations. Journal of Diabetes Science and Technology 7:6 (2013), 1652–1653.
Singer, P., Anbar, R., Cohen, J., Shapiro, H., Shalita-Chesner, M., Lev, S., Grozovski, E., Theilla, M., Frishman, S., Madar, Z., The tight calorie control study (TICACOS): A prospective, randomized, controlled pilot study of nutritional support in critically ill patients. Intensive Care Medicine 37:4 (2011), 601–609.
Sowell, M., Mukhopadhyay, N., Cavazzoni, P., Carlson, C., Mudaliar, S., Chinnapongse, S., Ray, A., Davis, T., Breier, A., Henry, R.R., Dananberg, J., Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: A prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. The Journal of Clinical Endocrinology & Metabolism 88:12 (2003), 5875–5880.
Steil, G.M., Rebrin, K., Janowski, R., Darwin, C., Saad, M.F., Modeling β-cell insulin secretion-implications for closed-loop glucose homeostasis. Diabetes Technology & Therapeutics 5:6 (2003), 953–964.
Stewart, K.W., Pretty, C.G., Tomlinson, H., Thomas, F.L., Homlok, J., Noemi, S.N., Illyes, A., Shaw, G.M., Benyo, B., Chase, J.G., Safety, efficacy and clinical generalization of the STAR protocol: A retrospective analysis. Annals of Intensive Care, 6(1), 2016, 24.
Stewart, K.W., Chase, J.G., Pretty, C.G., Shaw, G.M., Nutrition delivery, workload and performance in a model-based ICU glycaemic control system. Computer Methods and Programs in Biomedicine 166 (2018), 9–18.
Stewart, K.W., Chase, J.G., Pretty, C.G., Shaw, G.M., Nutrition delivery of a model-based ICU glycaemic control system. Annals of Intensive Care, 8(1), 2018, 4.
Suhaimi, F., Le Compte, A., Preiser, J.C., Shaw, G.M., Massion, P., Radermecker, R., Pretty, C., Lin, J., Desaive, T., Chase, J.G., What makes tight glycemic control (TGC) tight? The impact of variability and nutrition in 2 clinical studies. Journal of Diabetes Science and Technology 4:2 (2010), 284–298.
Symeonidis, P., Rizos, E., Andras, C., Hairistanidis, S., Manolopoulos, Y., Zanker, M., Deep reinforcement learning for personalized insulin dosing and glucose control of hospitalized in ICU patients. International Journal of Data Science and Analytics 20:7 (2025), 6841–6854.
Tanenberg, R.J., Hardee, S., Rothermel, C., Drake, A.J., 3rd, Use of a computer-guided glucose management system to improve glycemic control and address national quality measures: A 7-year, retrospective observational study at a Tertiary Care teaching hospital. Endocrine Practice : Official Journal of The American College of Endocrinology and the American Association of Clinical Endocrinologists 23:3 (2017), 331–341.
Tappy, L., Tounian, P., Paquot, N., Autoregulation of endogenous glucose production in man. Biochemical Society Transactions 25:1 (1997), 11–13.
Thomas, F., Signal, M., Harris, D.L., Weston, P.J., Harding, J.E., Shaw, G.M., Chase, J.G., Group, C.S., Continuous glucose monitoring in newborn infants: How do errors in calibration measurements affect detected hypoglycemia?. Journal of Diabetes Science and Technology 8:3 (2014), 543–550.
Thorsteinsson, B., Fugleberg, S., Feldt-Rasmussen, B., Ellemann, K., Binder, C., Kinetics models for insulin disappearance from plasma in type 1 diabetic patients. Pharmacol Toxicol 60:2 (1987), 90–95.
Thorsteinsson, B., Kinetic models for insulin disappearance from plasma in man. Danish Medical Bulletin 37:2 (1990), 143–153.
Toffolo, G., Campioni, M., Basu, R., Rizza, R.A., Cobelli, C., A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. American Journal of Physiology-Endocrinology and Metabolism 290:1 (2006), E169–E176.
Uyttendaele, V., Dickson, J.L., Shaw, G.M., Desaive, T., Chase, J.G., Untangling glycaemia and mortality in critical care. Critical Care (London, England), 21(1), 2017, 152.
Uyttendaele, V., Knopp, J.L., Pirotte, M., Guiot, J., Morimont, P., Lambermont, B., Shaw, G.M., Desaive, T., Chase, J.G., Preliminary results from the STAR-Liège clinical trial: Virtual trials, safety, performance, and compliance analysis. IFAC-PapersOnLine 51:27 (2018), 355–360.
Uyttendaele, V., Knopp, J.L., Stewart, K.W., Desaive, T., Benyó, B., Szabo-Nemedi, N., Illyés, A., Shaw, G.M., Chase, J.G., A 3D insulin sensitivity prediction model enables more patient-specific prediction and model-based glycaemic control. Biomedical Signal Processing and Control 46 (2018), 192–200.
Uyttendaele, V., Knopp, J.L., Shaw, G.M., Desaive, T., Chase, J.G., Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?. IFAC Journal of Systems and Control, 9, 2019, 100063.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., Bouillon, R., Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine 345:19 (2001), 1359–1367.
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., Van Wijngaerden, E., Bobbaers, H., Bouillon, R., Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354:5 (2006), 449–461.
Vanhorebeek, I., Langouche, L., Van den Berghe, G., Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness?. Current Opinion in Critical Care 11:4 (2005), 304–311.
Vanhorebeek, I., Langouche, L., Van den Berghe, G., Intensive insulin therapy in the intensive care unit: Update on clinical impact and mechanisms of action. Endocrine Practice 12 (2006), 14–21.
Venkatesan, P., Tiwari, A., Dasgupta, R., Carey, M., Kehlenbrink, S., Wickramanayake, A., Jambugulam, M., Jeyaseelan, L., Ramanathan, K., Hawkins, M., Surrogate measures of insulin sensitivity when compared to euglycemic hyperinsulinemic clamp studies in Asian Indian men without diabetes. Journal of Diabetes and its Complications 30:2 (2016), 287–291.
Weekers, F., Giulietti, A.P., Michalaki, M., Coopmans, W., Van Herck, E., Mathieu, C., Van den Berghe, G., Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144:12 (2003), 5329–5338.
Weissman, C., Nutrition in the intensive care unit. Critical Care (London, England), 3(5), 1999, R67.
Wernerman, J., Desaive, T., Finfer, S., Foubert, L., Furnary, A., Holzinger, U., Hovorka, R., Joseph, J., Kosiborod, M., Krinsley, J., Mesotten, D., Nasraway, S., Rooyackers, O., Schultz, M.J., Van Herpe, T., Vigersky, R.A., Preiser, J.C., Continuous glucose control in the ICU: Report of a 2013 round table meeting. Critical Care (London, England), 18(3), 2014, 226.
Wernerman, J., Christopher, K.B., Annane, D., Casaer, M.P., Coopersmith, C.M., Deane, A.M., De Waele, E., Elke, G., Ichai, C., Karvellas, C.J., McClave, S.A., Oudemans-van Straaten, H.M., Rooyackers, O., Stapleton, R.D., Takala, J., van Zanten, A.R.H., Wischmeyer, P.E., Preiser, J.C., Vincent, J.L., Metabolic support in the critically ill: A consensus of 19. Critical Care (London, England), 23(1), 2019, 318.
Wischmeyer, P.E., The evolution of nutrition in critical care: How much, how soon?. Critical Care (London, England), 17, 2013, S7 17 Suppl 1.
Wong, X.W., Chase, J.G., Shaw, G.M., Hann, C.E., Lotz, T., Lin, J., Singh-Levett, I., Hollingsworth, L.J., Wong, O.S., Andreassen, S., Model predictive glycaemic regulation in critical illness using insulin and nutrition input: A pilot study. Medical Engineering & Physics 28:7 (2006), 665–681.
Wong, J.H.K., Näswall, K., Pawsey, F., Chase, J.G., Malinen, S.K., Adoption of technological innovation in healthcare delivery: A psychological perspective for healthcare decision-makers. BMJ Innovations, 2023, 001003 bmjinnov-2022-.
Yamada, T., Shojima, N., Hara, K., Noma, H., Yamauchi, T., Kadowaki, T., Glycemic control, mortality, secondary infection, and hypoglycemia in critically ill pediatric patients: A systematic review and network meta-analysis of randomized controlled trials. Intensive Care Medicine, 2017.
